AstraZeneca and Daiichi Sankyo have moved swiftly to file for FDA approval of a second indication for their TROP2-directed antibody-drug conjugate datopotamab deruxtecan (Dato-DXd), this time for ...

A biomarker could help identify patients with lung cancer who are most likely to benefit from treatment with AstraZeneca and Daiichi Sankyo's TROP2-directed drug datopotamab deruxtecan (Dato-DXd).

DXD Capital storage facility to open at Maui Business Park in 2027. DXD Capital, a private equity investor and self storage developer, announced that it has executed a long-term ground lease for ...

At close: May 5 at 4:00:00 PM EDT ...

After all, I know, they know, we all know, how massive High School DxD is within its niche fanbase, which isn’t niche anymore, to be fair. True fans would always be more than happy to even get ...